To remain relevant in managed care, adoption of EHRs are crucial for outpatient surgery. Included are four reasons it's essential for surgery centers to adopt.
In 2009, hospitals and doctors were given financial incentives to adopt electronic health records (EHRs) through the Health Information Technology for Economic and Clinical Health (HITECH) Act. Ambulatory surgery centers (ASCs) were not eligible for these funds, and were therefore not incentivized like the rest of the healthcare system to implement the technology. The consequence of that differentiation is that the majority of ASCs are still charting on paper, even while the rest of the health system has moved to digital records.
As the health system continues to evolve and grow their managed care networks, hospitals and health systems are making significant investments into the ASC industry as a solution for cost-effectiveness, capacity, and better patient outcomes. EHR adoption is essential for ASCs to be seen as attractive partners in the managed health care space, with the ability to manage and share accurate data and in a secure and timely way, and to share and benchmark data on patient health outcomes.
Here’s four reasons why it’s absolutely essential for ASCs to adopt EHRs to remain relevant and competitive in the managed care environment:
Tara Vail is Chief Growth Officer at HST Pathways, a leading provider of end-to-end technology solutions in the ASC setting. She has deep expertise in helping healthcare organizations leverage information technology to improve operational efficiency and optimize revenue cycle management.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Opzelura May Reduce Need for Other Treatments in Atopic Dermatitis | AAD 2025
March 11th 2025Patients with atopic dermatitis who had not received biologics prior to treatment with Opzelura were able to avoid biologics during the 12 months after treatment with the topical nonsteroidal, finds study at American Academy of Dermatology Association annual meeting.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Supporting Patients with Type 1 Diabetes Through Education, Technology and Transparency
March 10th 2025Arti Masturzo, M.D., chief medical officer of CCS, spoke with MHE in this third part of a video series to share how CCS helps patients with type 1 diabetes effectively use glucose monitors and insulin pumps by providing clear guidance and troubleshooting support, recognizing that even minor errors in management can have significant health consequences.
Read More
Melanoma Treatment Advances Now Crossing into Other Skin Cancers
March 10th 2025Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with advanced basal cell carcinoma, squamous cell carcinoma and Merkel cell carcinoma, which is a rare and aggressive type of skin cancer.
Read More